Disclosed M&A deal value rose from 2013 to 2018, followed by a drop to less than half its value last year. Now, with healthcare a top priority globally, M&A budgets are expected to exceed $30B this year.

M&A volume in the Healthtech market which is nearing record highs, is partly driven by the global spread of COVID-19. Based on actual M&A activity in the first 3 quarters of 2020, the year is forecasted to close with over 300 deals.

Private Equity market activity has been steadily increasing over the last 10 years with some slowdown this year - at 34% of all recent deals.

As for the top buyers, PE firm Advent International was the most active acquirer in healthtech with 7 acquisitions over the last 12 months, followed by another PE - W2O, while strategic buyers Health Catalyst, Change Healthcare, eso, and Vitalhub are all tied at 3 deals for the year.